Literature DB >> 5004004

Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine.

R K Sikes, W F Cleary, H Koprowski, T J Wiktor, M M Kaplan.   

Abstract

Three series of experiments on rabies vaccines were carried out on rhesus monkeys using suckling-mouse-brain vaccine, rabbit-brain vaccine, duck-embryo vaccine, and purified, concentrated tissue-culture vaccine. The latter was prepared in a human diploid cell strain and inactivated with beta-propiolactone, and consisted of tissue-culture fluid concentrated 200-fold with a final infectivity titre of 10(9.8) plaque-forming units per ml before inactivation. In the first two series of experiments, several vaccines were tested for relative immunogenicity on a pre-exposure basis. In the third series, a successful model was developed in which a single inoculation of the tissue-culture vaccine administered after exposure to rabies virus, with or without accompanying standard doses of antirabies serum, was evaluated as a method of prevention. A single dose of the tissue-culture vaccine protected 7 out of 8 monkeys from death by street virus. Homologous or heterologous antirabies serum alone gave poor results. The results indicate great promise for prophylaxis in man with one dose, or perhaps a few doses, of highly concentrated, purified tissue-culture vaccine.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5004004      PMCID: PMC2427892     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  SUCCESSFUL IMMUNIZATION OF PRIMATES WITH RABIES VACCINE PREPARED IN HUMAN DIPLOID CELL STRAIN WI-38.

Authors:  T J WIKTOR; H KOPROWSKI
Journal:  Proc Soc Exp Biol Med       Date:  1965-04

2.  A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs.

Authors:  F B PECK; H M POWELL; C G CULBERTSON
Journal:  J Lab Clin Med       Date:  1955-05

3.  Investigating the rabies virus.

Authors:  K Hummeler; H Koprowski
Journal:  Nature       Date:  1969-02-01       Impact factor: 49.962

4.  Purification of rabies virus grown in tissue culture.

Authors:  F Sokol; E Kuwert; T J Wiktor; K Hummeler; H Koprowski
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

5.  Immune lysis of rabies virus-infected cells.

Authors:  T J Wiktor; E Kuwert; H Koprowski
Journal:  J Immunol       Date:  1968-12       Impact factor: 5.422

6.  Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin.

Authors:  T J Wiktor; F Sokol; E Kuwert; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

7.  Purified rabies vaccine: development and comparison of potency and safety with two human rabies vaccines.

Authors:  R K Sikes; O P Larghi
Journal:  J Immunol       Date:  1967-09       Impact factor: 5.422

8.  ANTIRABIES ANTIBODY RESPONSE IN MAN TO VACCINE MADE FROM INFECTED SUCKLING-MOUSE BRAINS.

Authors:  E FUENZALIDA; R PALACIOS; J M BORGONO
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

  8 in total
  29 in total

1.  An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.

Authors:  G M Baer; S A Moore; J H Shaddock; H B Levy
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells.

Authors:  J K Larson; W H Wunner; L Otvos; H C Ertl
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Role of host immune response in the development of either encephalitic or paralytic disease after experimental rabies infection in mice.

Authors:  Y Iwasaki; W Gerhard; H F Clark
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

5.  Rabies pathogenesis.

Authors:  F A Murphy
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

6.  Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.

Authors:  J W Templeton; C Holmberg; T Garber; R M Sharp
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

7.  Chronic rabies virus infection of cell cultures.

Authors:  T J Wiktor; H F Clark
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

8.  Immune response in primates vaccinated with duck embryo cell culture rabies vaccine.

Authors:  J F Lavender
Journal:  Appl Microbiol       Date:  1973-03

9.  Inhibitory effect of passive antibody on active immunity induced against rabies by vaccination.

Authors:  T J Wiktor; R A Lerner; H Koprowski
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

10.  Biological characterization of human monoclonal antibodies to rabies virus.

Authors:  B Dietzschold; M Gore; P Casali; Y Ueki; C E Rupprecht; A L Notkins; H Koprowski
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.